Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm

Fig. 6

Comparison between the sum of diameters (SOD), derived by the personalization algorithm, and the value measured from imaging assessments, at each clinically measured time point, for all patients, presented on a normal scale (a), and on a log scale (b). The reference line marks equality between the fitted and predicted SOD values. Values of 0 were excluded from the dataset for calculation of R-squared

Back to article page